Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043678

SVP and General Counsel sold 2,880 shares at $36.03 ($103,766)

  • SVP and General Counsel acquired 2,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2020-07-24 Option exercise +1,109 $7.80 $8,650 2,409 D: show line 1 in the form
Taylor Stacy L SVP and General Counsel 2020-07-24 Option exercise +1,771 $6.55 $11,600 4,180 D: show line 2 in the form
Taylor Stacy L SVP and General Counsel 2020-07-24 Sale −2,880 $36.03 $103,766 1,300 D: show line 3 in the form
Open-market sales · 2,880 sh · avg $36.03 · $103,766

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2020-07-24 Option exercise · Stock Option (Right to Buy) −1,109 38,363 D: show line 4 in the form
Taylor Stacy L SVP and General Counsel 2020-07-24 Option exercise · Stock Option (Right to Buy) −1,771 35,417 D: show line 5 in the form
Loading xslF345X03/doc4.xml…